Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders

E-ISSN： 1875-5666|16|5|465-473

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.16, Iss.5, 2016-06, pp. : 465-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical View on the Need to Develop New Anti-Diabetic Drugs

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 469-474

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Recent Progress in the Development of Anti-Diabetic Drugs (Guest Editor: J. Eckel)]

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 467-467

Bentham Science Publishers

Access to resources Recommend Favorite

Toward molecular diagnostics of mood disorders in psychiatry

By Avissar S. Schreiber G.

Trends in Molecular Medicine, Vol. 8, Iss. 6, 2002-06 ,pp. : 294-300

Elsevier

Access to resources Recommend Favorite

Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders

Current Molecular Medicine, Vol. 15, Iss. 3, 2015-03 ,pp. : 253-264

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Diabetic Foot Ulcers

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 7, Iss. 1, 2007-02 ,pp. : 95-104

Bentham Science Publishers

Access to resources Recommend Favorite